Prostate cancer screenings occur in 23 million men each year, with 250,000 being diagnosed with the affliction. In less severe cases, patients are quick to receive immediate treatment despite the fact...
that only 3% are likely to have a prostate cancer recurrence. Genomic Health is developing a test for prostate cancer patients, called the Oncotype DX Prostate Cancer Test (assay), which will help determine how aggressive the prostate cancer is and aides doctors and patients in forming an individualized course of treatment. Read more: http://bit.ly/ProstateOncotypeDX
Never miss a thing with our weekly newsletter. We'll send you the latest and greatest infographics, news and all things Visually.
Go ahead, you can always opt out anytime with just one click.
Switch to Wordpress Code
Click bellow to copy
Get Notified of New Infographics
Thank you for subscribing to the Visually newsletter.
Just one last thing: we've sent you an email asking you to confirm your subscription.
Tell your story visually before December 31st and get a free iPad Air!*
The holidays are a great time to tell your brand story. From Black Friday trends and Mobile Shopping guides to the Best and Worst Times to Book Travel and Thanksgiving etiquette, the Visually team will help you craft your brand's unique stories and raise your social profile during the noisy holiday season.